Efficacy and safety of low molecular weight heparin in renal transplantation

Transplantation

Volumn 66, Issue 4, 1998, Pages 533-534

  Alkhunaizi, Ahmed M ^a   Olyaei, Ali J ^a   Barry, John M ^a   DeMattos, Angelo M ^a   Conlin, Michael J ^a   Lemmers, Michael J ^a   Bennett, William M ^a   Norman, Douglas J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; WARFARIN;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; GRAFT REJECTION; HUMAN; HYPERCOAGULABILITY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SUBCLAVIAN VEIN; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; THROMBOPHLEBITIS;

EID: 0032572707     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808270-00020     Document Type: Article

References (10)

1. Rijksen JF, Koolen MI, Walaszewski JE, Terpstra JL, Vink M. Vascular complications in 400 consecutive renal allotransplants. J Cardiovasc Surg 1982; 23: 91.
2. Bakir N, Sluiter WJ, Ploeg RJ, van Son WJ, Tegzess AM. Primary renal graft thrombosis. Nephrol Dial Transplant 1996; 11: 140.
3. Abramowicz D, Pradier O, Marchant A, et al. Induction of thromboses within renal grafts by high-dose prophylactic OKT3. Lancet 1992; 339: 777.
4. Verpooten GA, Cools FJ, Van der Planken MG, et al. Elevated plasminogen activator inhibitor levels in cyclosporin-treated renal allograft recipients. Nephrol Dial Transplant 1996; 11: 347.
5. Fricker JP, Vergnes Y, Schach R, et al. Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery. Eur J Clin Invest 1988; 18: 561.
6. Jorgensen PS, Knudsen JB, Broeng L, et al. The thromboprophylactic effect of a low-molecular-weight heparin (Fragmin) in hip fracture surgery: a placebo-controlled study. Clin Orthop 1992; 278: 95.
7. Albada J, Nieuwenhuis HK, Sixma JJ. Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin): results of a double-blind randomized study. Circulation 1989; 80: 935.
8. Pradier O, Marchant A, Abramowicz D, et al. Procoagulant effect of the OKT3 monoclonal antibody: involvement of tumor necrosis factor. Kidney Int 1992; 42: 1124.
9. Noel C, Hazzan M, Coppin MC, Pruvot FR, Bridoux F, Lelievre G. Renal transplant artery thrombosis following treatment of allograft rejection with monoclonal anti-CD3 antibodies (OKT3). Transplant Proc 1995; 27: 2438.
10. Broyer M, Gagnadoux MF, Sierro A, Fischer AM, Niaudet P. Preventive treatment of vascular thrombosis after kidney transplantation in children with low molecular weight heparin. Transplant Proc 1991; 23: 1384.